HQL
abrdn Life Sciences Investors$19.37+0.18 (+0.94%)Prev Close$19.19·MCap$486.4M·P/E—·Vol201.6K·Yield—
▲
Buys (12M)
2
$144.3K
▼
Sells (12M)
0
$0.00
◆
Net Activity
Net Buyer
$144.3K
●
Active Insiders
2
last 12 mo
Over the past 12 months, insider activity at abrdn Life Sciences Investors (HQL) has been exclusively buying, with 2 insider purchases totaling $144.3K and 0 insider sales totaling $0.00. The most recent insider transaction was by Mahai Chris LaVictoire (director), who purchased $10.5K worth of shares on Jul 20, 2026. abrdn Life Sciences Investors operates in the Financial Services sector, within the Asset Management industry, with a market cap of $486.4M.
HQL Insider Trading Activity
HQL Insider Buying Activity
The following table shows recent insider purchases of abrdn Life Sciences Investors (HQL) stock reported via SEC Form 4 filings.
HQL Insider Selling Activity
The following table shows recent insider sales of abrdn Life Sciences Investors (HQL) stock reported via SEC Form 4 filings.